baber/WOPTO huggingface dataset:
Patent CA-2555626-A1 (CA)
Title: Suction head for a vacuum cleaner
Inventor: GREY NICHOLAS GERALD
IPC: A47L9/02
Filed: 2006-08-04
Abstract: A suction head for a vacuum cleaner comprises a hollow body including a pair of arms which diverge from a predetermined region of the body at an angle less than 180 degrees relative to each other. Each arm is formed with a channel for the passage of air, the channel extending from the free end of the arm to the region of the body from which the arms diverge. An outlet opening is located in the region of the body from which the arms diverge for the passage of air to a vacuum cleaner. A first continuous ground-engaging barrier extends along the region of an inner edge of one of the arms from the free end of the arm to the region of the body from which the arms diverge. A second continuous ground- engaging barrier extends along the region of an inner edge of the other of the arms from the free end of the arm to the region from which the arms diverge. A gap is formed between the first and second barriers in the region from which the arms diverge for the passage of relatively large particles of debris into the suction head. The first and second barriers are adapted to engage a flat ground surface along the entire length of the first and second barriers.
Patent CA-2556881-A1 (CA)
Inventor: FUCCELLA DANIEL C
IPC: E04F15/10
Filed: 2005-02-22
Abstract: An interlocking, modular floor tile that comprises a planar member defined by a perimeter having four sides and a top surface, a plurality of downwardly projecting support legs of common length dispersed pattern-wise inside the perimeter of the planar member and coupled with the top surface, and at least one female interlocking connector element that extends outside the perimeter of the planar member for receiving a support leg of a like tile and thereby forming an interlock with the like tile.
Patent CA-2561737-A1 (CA)
Inventor: MIYAMOTO NORIFUMI
IPC: C04B35/80
Filed: 2005-02-17
Abstract: A process which comprises: a molding formation step in which a fibrous molding is formed from short fibers of silicon carbide having a heat resistance of 1,000~C or higher; a sol-gel solution preparation step in which a sol-gel solution containing a heat-resistant compound having a heat resistance of 1,000~C or higher is prepared; an impregnation/drying/calcinations step in which the fibrous molding is impregnated with the sol-gel solution, dried, and calcined; and a crystallization step in which the impregnated, dried, and calcined fibrous molding is crystallized.
Patent CA-2564778-A1 (CA)
Inventor: VAN MECHELEN MARCELLE PAULETTE
IPC: A61K39/02
Filed: 2005-05-19
Abstract: The present invention provides a vaccine composition comprising the B subunit of Shiga toxin or an immunologically functional equivalent thereof which is able to bind the Gb3 receptor, complexed with an antigen, and further comprising an adjuvant, provided that when the adjuvant is solely a metal salt it is formulated in such a way that not more than about 50% of the antigen is adsorbed onto the metal salt. Such compositions provide an improved immune response compared to Shiga toxin or an immunologically functional equivalent thereof complexed with an antigen with no adjuvant, or an antigen alone with adjuvant.
Patent CA-2565812-A1 (CA)
Title: 4-phenylamino-quinazolin-6-yl-amides
Inventor: TECLE HAILE
IPC: A61K31/5377
Filed: 2005-04-25
Abstract: The invention provides quinazoline compounds of the formula: wherein R1 is halo; R2 is H or halo; R3 is a) C1-C3 alkyl, optionally substituted by halo;  or b) -(CH2)n-morpholino, -(CH2)n-piperidine, -(CH2)n-piperazine, -(CH2)n-piperazine-N(C1-C3 alkyl), -(CH2)n-pyrrolidine, or -(CH2)n imidazole; n is 1 to 4; R4 is -(CH2)m-Het; Het is morpholine,piperidine, piperazine, piperazine-N(C1-C3 alkyl), imidazole,pyrrolidine, azepane, 3,4-dihydro-2H-pyridine, or 3,6-dihydro-2H-pyridine, each optionally substituted by alkyl, halo, OH, NH2, NH(C1-C3 alkyl) or N (C1-C3 alkyl)2; m is 1-3; and X is O, S or NH; or a pharmaceutically acceptable salt thereof, as well as processes and intermediate compounds for making them, useful pharmaceutical compositions and methods of using the compounds in the treatment of proliferative diseases.
Patent CA-2567250-A1 (CA)
Inventor: SILVERBROOK KIA
IPC: G06K19/10
Filed: 2005-01-24
Abstract: Coded data for disposal on or in a surface, the coded data including a number of coded data portions, each coded data portion encoding: an identity; and, at least part of a signature, the signature being a digital signature of at least part of the identity.
Patent CA-2567341-A1 (CA)
Title: Process for applying multi-component composite coatings to substrates to provide sound damping and print-through resistance
Inventor: DESAI UMESH C
IPC: B05D7/14
Filed: 2005-05-25
Abstract: A process is provided for applying multi-component composite coating compositions to substrates to provide sound damping and print-through resistance. The process includes applying at least one first coating composition to a surface of the substrate; applying at least one second coating composition over the first; and curing one or both of the first and second compositions, thereby forming a multi-layered coated substrate. The coating compositions may be applied by a method selected from spraying, extruding, brushing, and/or dipping.
Patent CA-2567667-A1 (CA)
Title: Method and communication apparatus for reproducing a moving picture, and use in a videoconference system
Inventor: DUFOSSE STEPHANE
IPC: H04N7/15
Filed: 2006-11-09
Abstract: The invention relates to a method for reproducing a moving picture composed of a succession of images and of monophonic sounds, comprising the steps of :  determining spatial location of at least one zone In motion within said moving picture to be reproduced by analyzing successive images; identifying said zone in motion as corresponding to a source (P3) from which sound is originated; and reproducing said succession of images on a display (20) and corresponding sounds on at least one left loud speaker (21) and one right loud speaker (22), while applying to said sounds at least an audio 3D effect as a function of said spatial location.   Application to videoconference, mobile TV
Patent CA-2568491-A1 (CA)
Title: Landfill including highly permeable zones
Inventor: THOMAS MICHAEL
IPC: E02D17/00
Filed: 2006-11-22
Abstract: A landfill and method for constructing a landfill including a plurality of waste layers, each waste layer separated by highly permeable material layer and at least one vertical gas extraction well having a perforated casing the penetrates at least one of the highly permeable material layers.
Patent CA-2571817-A1 (CA)
Inventor: MERANTE FRANK
IPC: C12Q1/68
Filed: 2005-06-30
Abstract: The present invention describes a method for the simultaneous identification of two or more mutations located in the gene encoding Cytochrome P450-2C9.  Multiplex detection is accomplished using multiplexed tagged allele specific primer extension (ASPE) and hybridization of such extended primers to a probe, preferably an addressable anti-tagged support.
Patent CA-2572589-A1 (CA)
Title: Juicer
Inventor: BARKER MARIO JOHN CHAVES
IPC: A47J43/25
Filed: 2004-07-13
Abstract: This invention concerns a juicer (10), that is a machine for extracting the juice from fruit and vegetables. Such machines are used domestically, and also commercially in restaurants, cafes and juice bars. The invention comprises an electric motor (22), a shredder (25) mounted for rotation by the motor, a feed tube (43) to deliver pieces to be juiced to the shredder for juicing, wherein the feed tube has an inner diameter of more than 75mm, and three, or more, inwardly directed formations are arranged to constrict the interior of the feed tube. The inner diameter of the feed tube may be large enough for a typical apple to pass through it whole such as 85mm or more. The inwardly directed formations serve to prevent the insertion of a hand or arm into or through the feed tube despite its large diameter.
Patent CA-2574450-A1 (CA)
Title: Method of treating hyperphosphataemia using lanthanum hydroxycarbonate
Inventor: GILMOUR DAVID
IPC: A61K33/244
Filed: 2005-07-27
Abstract: This disclosure relates to the treatment of subjects at risk for chronic kidney disease (CKD), having stage one to five CKD, having hyperphosphataemia, susceptible to or suffering from soft tissue calcification associated with CKD, or susceptible to or suffering from hyperparathyroidism, by orally administering a pharmaceutical composition containing a therapeutically effective amount of lanthanum hydroxycarbonate.
Patent CA-2574463-A1 (CA)
Title: Nanocoating for improving biocompatibility of medical implants
Inventor: TANG LIPING
IPC: C12N15/88
Filed: 2005-04-20
Abstract: A coating for an implant surface comprising one or more nanoparticles of less than or equal to 500 nanometers and an implant surface capable of receiving the nanoparticles, the implant selected from the group consisting of metal, carbon, graphite, polymer, protein, nucleic acid, microorganisms, hydrogel, liquid, porous and polymer blend particles, and combinations thereof. The coating promotes characteristics on the implant surface such as reducing protein unfolding, preventing inflammatory and fibrotic cell accumulation, reducing the number of such cell attachment sites and preventing other adverse biological reactions. The coating may be applied on any material via physical and/or chemical binding. The coating may further comprise a surfactant and may include a tag, adsorbed, absorbed or incorporated onto the nanoparticle. The coating on an implant surface is used for purposes that may be cosmetic, therapeutic, preventative, reconstructive, monitoring and replacement. The coating may also be used for in vitro purposes.
Patent CA-2576818-A1 (CA)
Title: Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
Inventor: HONOLD KONRAD
IPC: A61P35/00
Filed: 2005-08-30
Abstract: The present invention relates to novel amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, to a process for their manufacture, medicaments containing them and their manufacture as well as the use of these compounds as pharmaceutically active agents. The present derivatives are new compounds of the general formula (I).
Patent CA-2582369-A1 (CA)
Inventor: PAGILAGAN ROLANDO UMALI
IPC: F16L9/19
Filed: 2005-10-27
Abstract: Marine umbilicals are provided comprising polyamide compositions having good hydrolysis resistance and that may optionally contain plasticizer.
Patent CA-2585507-A1 (CA)
Title: Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof
Inventor: SAXENA BRIJ B
IPC: C07K14/59
Filed: 2005-09-26
Abstract: The present invention relates to a chimeric nucleic acid molecule encoding a fusion protein having a human lutropin hormone-receptor domain and a human chorionic gonadotropin-.beta. subunit domain, the isolated human lutropin hormone-receptor/human chorionic gonadotropin- .beta. fusion protein, and antibodies which recognize part or all the domains of the fusion protein. Also provided are compositions having the human lutropin hormone-receptor/human chorionic gonadotropin-.beta. fusion protein and a pharmaceutical carrier and compositions including antibodies to the fusion protein and a pharmaceutical carrier. The present invention also relates to methods of treating androgen-excess-mediated disease conditions by administering to a subject an antibody to the human lutropin hormone-receptor/human chorionic gonadotropin-.beta.  fusion protein under conditions suitable to treat the conditions, and methods of immunocontraception that involve administering to a subject the chimeric nucleic acid molecule encoding the human lutropin hormone receptor/human chorionic gonadotropin-.beta. fusion protein, the fusion protein in whole or in part, or antibodies thereto.
Patent CA-2585844-A1 (CA)
Title: Sac a compartiments detachables
Inventor: PELLETIER GASTON
IPC: B65D33/00
Filed: 2007-04-23
Abstract: Sac à compartiments détachables se logeant dans un récipient ayant un rebord périphérique supérieur définissant une ouverture. Une section de sac supérieure a une profondeur et une étendue telles que la section est rabattable contre le rebord du récipient de manière à y adhérer. Au moins deux sections de sac inférieures s'étendent côte à côte de manière complémentaire et forment chacune un des compartiments détachables. Les sections inférieures se projettent sous la section supérieure et ont des parois adjacentes dont des extrémités supérieures s'élèvent à  une hauteur du sac correspondant à la profondeur de la section supérieure. Un dispositif de liaison détachable lie la section supérieure et les sections inférieures ensemble. Le dispositif s'étend à travers des parois opposées de la section supérieure et entre les extrémités supérieures des parois adjacentes des sections inférieures de façon à définir une ligne de séparation en forme de U.
Patent CA-2586705-A1 (CA)
Inventor: WALSH ALLAN
IPC: A61M5/50
Filed: 2005-04-04
Abstract: A safety syringe comprising a syringe barrel (12), a plunger (13), a needle (14), a needle hub (15) integral with the needle, a needle gland (16) to accommodate the needle and hub, and a needle cap (19) to protect the needle prior to use. The plunger has engagement means (25, 36) located on its end to engage with the needle hub in order to retract the needle from the gland and into the syringe barrel after the syringe has been used. The plunger is provided with a threaded split bush (28), which has a multi start thread. When the plunger is fully retracted with the needle attached, the plunger has one or more lugs (31) that come into contact with the threaded split bush so that the plunger is thereby locked. Hence the needle is locked in the barrel. The plunger may be snapped off retaining the needle safely within the syringe barrel.
Patent CA-2588672-A1 (CA)
Inventor: TAMURA JUNICHI
IPC: B25C7/00
Filed: 2005-11-24
Abstract: A contact member (10) is held by a nose section (4) and has engagement claws (23, 24) oriented to a fore-end direction. A vertical guide (12) has a pair of chuck members (13) that are rotatably arranged opposite to each other with a drive-in axis line in between so as to guide a screw or nail along the drive-in axis line and are rotatably urged by an elastic means in the direction that causes fore-end sections (22) to approach each other. The vertical guide (12) is provided so as to be slidable relative to the nose section (4) in the direction to eject the screw or nail. The vertical guide (12) is springly urged so that, in a normal state, the fore-end section of the vertical guide (12) projects out from the engagement claws (23, 24) of the contact member (10).
Patent CA-2589519-A1 (CA)
Inventor: BOOTH REBECCA J
IPC: A61K31/16
Filed: 2005-12-14
Abstract: The invention relates to a compound selected from one or more of the following: a tris (hydroxymethyl) methylamine salt of (2S)-2- ethoxy-3-(4-{2-[hexyl (2-phenylethyl) amino]-2- oxoethoxy} phenyl) propanoic acid; an ethanol amine salt of (2S)-2-ethoxy-3- (4-{2-[hexyl (2-phenylethyl) amino]-2-oxoethoxy} phenyl) propanoic acid; or a pharmaeutical composition comprising the compound.
Patent CA-2590587-A1 (CA)
Inventor: DALY MARY
IPC: G08B17/10
Filed: 2007-02-25
Abstract: The invention provides a device that reminds people to test their smoke alarms regularly. At fixed time intervals, typically 30 days, the device's internal timer expires, and an indicator on the device (the reminder) activates. The indicator can be visual, audible or both. A manual reset button is provided to reset the timer and deactivate the indicator after all smoke alarms have been tested. An alternate embodiment of this reminder device includes an audio detector that automatically resets the device when the device is held close to a smoke alarm that is being tested. This reminder device is simple enough that it can be packaged as a self-contained, compact, lightweight unit that can be mounted in any high-traffic location in the home, where it is most likely to be noticed.
Patent CA-2591541-A1 (CA)
Inventor: NYE PAMELA
IPC: G16Z99/00
Filed: 2005-12-14
Abstract: A handheld computing device for use in hospitals, operating rooms, and other medical care facilities. The handheld computing device includes a processor, display, user interface, memory, one or more embedded environmental sensors, and one or more scanners for reading identifier codes that uniquely identify sterile and non-sterile supplies, instruments and disposable components thereof and other inventory items and supplies that are used in the course of a medical procedure such as surgery. To manage the accounting of various items used in an operating room for example, the handheld computing device is provided with an RF tag reader and a barcode reader to read and identify medical items that are used in the course of a medical procedure. In the course of scanning such identifier codes, the handheld computing device receives inventory accounting information that is stored within the memory of the device, and which can be subsequently downloaded and transferred to one or more external databases. Further, in one embodiment, the environmental sensors may include temperature, humidity and pressure sensors that sense, record and store temperature, humidity and pressure data.
Patent CA-2592283-A1 (CA)
Title: Oral care compositions containing free-b-ring flavonoids, flavans and a bioavailability enhancer
Inventor: HAO ZHIGANG
IPC: A61K8/25
Filed: 2005-12-21
Abstract: Oral care compositions containing: a free-B-ring flavonoid and a flavan; as well as at least one bioavailability-enhancing agent are provided. Methods of using the oral compositions are also provided.
Patent CA-2592470-A1 (CA)
Title: Method for inducing differentiation to skeletal muscle cells
Inventor: NABESHIMA YO-ICHI
IPC: A61P21/04
Filed: 2005-12-22
Abstract: A method of efficiently and conveniently inducing differentiation from bone marrow stromal cells to skeletal muscle cells, which comprises the steps of: (a) the step of adding one or more kinds of substances selected from the group consisting of a cyclic AMP increasing agent, a cAMP analogue, and a cell differentiation stimulating factor to a culture of bone marrow stromal cells, wherein said bone marrow stromal cells are not treated with a demethylating agent, and culturing the cells; (b) the step of introducing a Notch gene and/or a Notch signaling related gene into the cells obtained in the step (a), and culturing the cells to obtain a culture of myoblasts, provided that said culture does not contain the cells introduced with the gene and non-introduced cells; and (c) the step of adding a Notch ligand to the culture of myoblasts obtained in the step (b), and culturing the cells.
Patent CA-2592908-A1 (CA)
Title: Line diagnostic device, bus system, line diagnostic method, bus system control method, and line diagnostic program
Inventor: FUNAKI SATORU
IPC: G06F11/30
Filed: 2007-06-27
Abstract: A control device diagnoses the operation of a bus arbiter that mediates bus usage requests output by multiple devices in the control device to satisfy both responsiveness and safety. A diagnostic module, implemented as an external diagnostic module, monitors signals related to the arbiter mediation and, if an abnormality caused by a signal sticking condition or an abnormality in a mediation control unit is detected, stops data transfer safely to prevent safety data from being output incorrectly.
Patent CA-2593610-A1 (CA)
Inventor: BAKER MATTHEW P J
IPC: H04L47/56
Filed: 2006-01-10
Abstract: L'invention concerne un procédé d'exploitation d'un système de communication comprenant une station de communication (UE1) et une autre station (BS), ces stations étant dotées de moyens (26, 10) leur permettant de communiquer entre elles, et la station de communication comprenant des moyens mémoire tampon (BUF1 à BUFn) destinés à stocker des unités de données dans au moins une file d'attente. Une des stations (UE1, BS) comprend un moyen (36) d'estimation du retard de transmission d'au moins une des unités de données dans la file d'attente au moins, et un moyen (30) sensible à un retard de transmission estimé dépassant une valeur seuil, servant à demander une permission à l'autre station (BS) pour permettre à la station de communication (UE1) de transmettre au moins une unité de données à l'autre station (BS). Cette autre station (à savoir, la station de base) "accorde" la permission (sous la forme d'une acceptation d'une certaine vitesse) de transmettre à un certain niveau de puissance, ou de transmettre pendant une certaine durée.
Patent CA-2594919-A1 (CA)
Inventor: SOUTSCHEK JUERGEN
IPC: A61K48/00
Filed: 2006-01-24
Abstract: The invention relates to compositions and methods for modulating the expression of Nogo-L or Nogo-R genes, and more particularly to the downregulation of Nogo-L or Nogo-R by chemically modified oligonucleotides.
Patent CA-2597239-A1 (CA)
Inventor: EHRMAN GEOFFREY N
IPC: B32B37/06
Filed: 2007-08-14
Abstract: A drainage-promoting wrap includes an elongate web of a weather-resistive membrane and a series of separate, laterally spaced-apart, elongate filament spacers bonded to a face of the membrane. The filaments are preferably extruded polymeric filaments and have depressions formed therein providing transverse drainage paths across the filaments. Preferably, the filaments extend substantially parallel to each other and to a longitudinal axis of the elongate membrane. In addition, preferably the membrane is made of a polymeric material so that the filaments are thermally bonded to the face of the membrane. Wall and roof assemblies utilizing the wrap and methods of making the wrap are provided.
Patent CA-2597395-A1 (CA)
Title: Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
Inventor: MARTIN ALAIN
IPC: A61K31/195
Filed: 2006-02-10
Abstract: The present invention provides a method for treating wounds and diseases in mammals, caused by mammalian cells involved in an inflammatory response, by altering indigenous in vivo levels of peroxynitrous acid, and salts thereof.  The method comprises contacting the mammalian cells with a therapeutically effective amount of a reactive oxygen species mediator, wherein the reactive oxygen species mediator is selected from the group consisting of pyruvates, pyruvate precursors, a- keto acids having four or more carbon atoms, precursors of ce-keto acids having four or more carbon atoms, and the salts thereof, wherein mediation of reactive oxygen species results in mediation of peroxynitrous acid. The present invention further provides a pharmaceutical composition for treating wounds and diseases in mammals, caused by mammalian cells involved in an inflammatory response, by altering indigenous in vivo levels of peroxynitrous acid, and salts thereof.
Patent CA-2598553-A1 (CA)
Title: Polyurethane light guides
Inventor: JOSEPH EDMOND KENNETH
IPC: A61C13/15
Filed: 2005-12-16
Abstract: A light guide (1) formed from an unclad flexible polyurethane fibre produces significant side scattering (2) over distances of up to several metres. The polyurethane fibre is in the form of a solid fibre or a tube and may comprise light scattering particles. The polyurethane fibre may comprise a transparent flexible polyurethane UV resistant outer cladding. Embodiments include illuminated shoe laces, a power cord safety indicator, an illuminated dental suction tube and a dental curing tip.
Patent CA-2599079-A1 (CA)
Title: Solid state power controller with lightning protection
Inventor: MAIER JOSEF
IPC: B64D45/02
Filed: 2007-08-27
Abstract: A method of controlling a solid state power controller includes selectively allowing a transient current through a solid state power control switch in response to the transient current exceeding at least one threshold.